| PRP/024/23FX | Preclinical development of a cancer vaccine for hepatocellular carcinoma treatment | 1574467 | 2024 |
| PiH/010/24 | Development of Humanized Monoclonal NID1 Antibody and Analysis of Its Pre-clinical Efficacy in Treating Liver Cancer | 820983 | 2024 |
| ITS/257/22 | Development of Humanized Monoclonal NID1 Antibody and Analysis of Its Pre-clinical Efficacy in Treating Liver Cancer | 1390028 | 2023 |
| RFS2324-7S01 | The role of exomere, a new family member of extracellular vesicles, in liver cancer | 5155380 | 2023 |
| 17105322 | Role of sodium-hydrogen exchanger in the regulation of extracellular vesicle uptake in hepatocellular carcinoma | 1020220 | 2022 |
| 09202326 | The blockage of tumor-endothelial crosstalk as a therapeutic approach for liver cancer | 1497582 | 2021 |
| InP/420/21 | The Production, Optimization and Preclinical Efficacy of Monoclonal Antibody for Targeting Oncogenic NID-Enriched Extracellular Vesicles in Liver Cancer | 228585 | 2021 |
| PiH/092/21 | The Production, Optimization and Preclinical Efficacy of Monoclonal Antibody for Targeting Oncogenic NID-Enriched Extracellular Vesicles in Liver Cancer | 603000 | 2020 |
| PiH/091/21 | The Production, Optimization and Preclinical Efficacy of Monoclonal Antibody for Targeting Oncogenic NID-Enriched Extracellular Vesicles in Liver Cancer | 603000 | 2020 |
| InP/073/21 | The Production, Optimization and Preclinical Efficacy of Monoclonal Antibody for Targeting Oncogenic NID-Enriched Extracellular Vesicles in Liver Cancer | 373427 | 2020 |
| InP/072/21 | The Production, Optimization and Preclinical Efficacy of Monoclonal Antibody for Targeting Oncogenic NID-Enriched Extracellular Vesicles in Liver Cancer | 396900 | 2020 |
| ITS/228/20 | The Production, Optimization and Preclinical Efficacy of Monoclonal Antibody for Targeting Oncogenic NID-Enriched Extracellular Vesicles in Liver Cancer | 1370409 | 2020 |
| 17105721 | Extracellular vesicle NAMPT of hepatocellular carcinoma: Functional role and clinical relevance | 1153052 | 2021 |
| 06172066 | Galectin-9 is a potential dual treatment target for tumor cells and the immune micro-environment of lung adenocarcinoma | 1321176 | 2018 |
| 17119120 | Tumor extracellular vesicle-mediated signaling activates ketolysis to fuel cancer cell growth and metastasis in liver cancer | 1195024 | 2020 |
| 17117519 | Exosomal NID1 facilitates extrahepatic metastasis by inducting TNFR1 secretion from pulmonary lung fibroblasts | 1114799 | 2019 |
| 17102115 | Functional role of caveolin-1-mediated S100P in liver cancer metastasis under hypoxic stress | 981146 | 2015 |
| 17100418 | Suppression of fatty acid oxidation by caveolin-1 contributes to hepatocellular carcinoma progression | 925020 | 2018 |
| HKU 783310M | Interplay of caveolin-1 and met receptor in liver cancer metastasis | 887400 | 2010 |
| HKU 7674/06M | Characterization of tensin2, the binding partner of DLC1 tumor suppressor in liver cancer | 932500 | 2006 |
| HKU 779807M | Nucleocytoplasmic shuttling mechanism of DLC1 tumor suppressor in liver cancer | 1388110 | 2007 |
| HKU 783613M | Clinical relevance and functions of nuclear Met in hepatocellular carcinoma metastasis | 1108944 | 2013 |
| 13121302 | Role of caveolim-1 in hepatitis B virus-induced hepatocarcinogenesis | 977452 | 2013 |
| 17124814 | Functional role and clinical significance of galectin-1 in liver cancer | 725406 | 2014 |
| 02132846 | Functional role of hypoxia-induced caveolin-1 in hepatocellular carcinoma metastasis | 856120 | 2014 |
| 17113116 | Exosomes released from nuclear Met expressing cells promote liver cancer metastasis and formation of lung premetastatic niche | 933936 | 2016 |
